Targeting Nrf2 to decrease mitochondrial OXPHOS-driven oxidative stress in keratinocytes has been reported to attenuate IL-17A-induced psoriasis by regulating the bioenergetic metabolism [48]. This evidence concerns the gene IL17A and psoriasis.